Stereotaxis (STXS) filed a shelf registration statement with the US Securities and Exchange Commission on late Friday for the potential sale of up to $100 million in securities, to be offered from time to time.

The filing covers debt securities, common stock, preferred stock, warrants, rights and units.

The company said it intends to use the net proceeds for general corporate purposes, including acquisitions, debt repayment, capital expenditures, and working capital.